What does EPSILON-BIOTECH do?

EPSILON-BIOTECH is a research organisation in Zonhoven. Private Limited, started on 6 December 1994, 1 establishment.

What is the address of EPSILON-BIOTECH?

The registered office of EPSILON-BIOTECH is located at Beverzakbroekweg 91, 3520 Zonhoven.

Is EPSILON-BIOTECH still active?

Yes. According to the CBE (30 October 2026) EPSILON-BIOTECH is active, legal situation “Normale toestand”, started on 6 December 1994.

Is EPSILON-BIOTECH registered on Peppol?

Yes, EPSILON-BIOTECH is registered on the Peppol network with ID 0208:0453963661.

What is the enterprise number of EPSILON-BIOTECH?

The enterprise number of EPSILON-BIOTECH is BE0453963661.

When was EPSILON-BIOTECH founded?

EPSILON-BIOTECH was founded on 6 December 1994.

Who are the directors of EPSILON-BIOTECH?

According to the 2025 annual accounts, the directors of EPSILON-BIOTECH are: Eugenius Bosmans.

Is EPSILON-BIOTECH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 1994; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did EPSILON-BIOTECH make in 2025?

EPSILON-BIOTECH posted a profit after taxes of € 17,279 in financial year 2025.

What is the revenue of EPSILON-BIOTECH?

As a small company, EPSILON-BIOTECH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 42,143.

Does EPSILON-BIOTECH have a website?

Yes, EPSILON-BIOTECH has a website at epsilon-biotech.be.

EPSILON-BIOTECH (Private Limited) - Zonhoven

Dossier EPSILON-BIOTECH, printed on 30 October 2026 from databakkes.be/en/0453963661/epsilon-biotech. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

EPSILON-BIOTECH from Zonhoven, company number BE0453963661, closed financial year 2025 with a result of € 17,279 after tax. For that financial year EPSILON-BIOTECH recorded a gross margin of € 42,143 and equity of € 220,466. Compared with financial year 2024, the result moved from € 46,514 to € 17,279. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 31, 2025.

What it is worth Growing

€ 220,466

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 17,279

▼ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 91,519

▲ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 87,466.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 22,820

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 294

▼ 89% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 61

▼ 99% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 36,395 Gross margin 2022: € 36,395 First fiscal year in the series	€ 64,903 Gross margin 2023: € 64,903 ▲ 78% vs 2022 (€ 36,395) Favourable step	€ 74,702 Gross margin 2024: € 74,702 ▲ 15% vs 2023 (€ 64,903) Favourable step	€ 42,143 Gross margin 2025: € 42,143 ▼ 44% vs 2024 (€ 74,702) Unfavourable step	▼ 44%
Profit after taxes	€ 30,182 Profit after taxes 2022: € 30,182 First fiscal year in the series	€ 51,910 Profit after taxes 2023: € 51,910 ▲ 72% vs 2022 (€ 30,182) Favourable step	€ 46,514 Profit after taxes 2024: € 46,514 ▼ 10% vs 2023 (€ 51,910) Unfavourable step	€ 17,279 Profit after taxes 2025: € 17,279 ▼ 63% vs 2024 (€ 46,514) Unfavourable step	▼ 63%
Equity	€ 104,763 Equity 2022: € 104,763 First fiscal year in the series	€ 156,673 Equity 2023: € 156,673 ▲ 50% vs 2022 (€ 104,763) Favourable step	€ 203,187 Equity 2024: € 203,187 ▲ 30% vs 2023 (€ 156,673) Favourable step	€ 220,466 Equity 2025: € 220,466 ▲ 9% vs 2024 (€ 203,187) Favourable step	▲ 9%
Total debts	€ 75,582 Total debts 2022: € 75,582 First fiscal year in the series	€ 32,700 Total debts 2023: € 32,700 ▼ 57% vs 2022 (€ 75,582) Favourable step	€ 26,804 Total debts 2024: € 26,804 ▼ 18% vs 2023 (€ 32,700) Favourable step	€ 24,319 Total debts 2025: € 24,319 ▼ 9% vs 2024 (€ 26,804) Favourable step	▼ 9%
Cash	€ 76,488 Cash 2022: € 76,488 First fiscal year in the series	€ 68,558 Cash 2023: € 68,558 ▼ 10% vs 2022 (€ 76,488) Unfavourable step	€ 55,626 Cash 2024: € 55,626 ▼ 19% vs 2023 (€ 68,558) Unfavourable step	€ 91,519 Cash 2025: € 91,519 ▲ 65% vs 2024 (€ 55,626) Favourable step	▲ 65%
Retained profit	€ -28,237 Retained profit 2022: € -28,237 First fiscal year in the series	€ 23,673 Retained profit 2023: € 23,673 ▲ € 51,910 vs 2022 (€ -28,237) Favourable step	€ 70,187 Retained profit 2024: € 70,187 ▲ 196% vs 2023 (€ 23,673) Favourable step	€ 87,466 Retained profit 2025: € 87,466 ▲ 25% vs 2024 (€ 70,187) Favourable step	▲ 25%
Balance sheet total	€ 180,346 Balance sheet total 2022: € 180,346 First fiscal year in the series	€ 189,373 Balance sheet total 2023: € 189,373 ▲ 5% vs 2022 (€ 180,346) Unchanged	€ 229,991 Balance sheet total 2024: € 229,991 ▲ 21% vs 2023 (€ 189,373) Unchanged	€ 244,785 Balance sheet total 2025: € 244,785 ▲ 6% vs 2024 (€ 229,991) Unchanged	▲ 6%

Key figures of EPSILON-BIOTECH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to EPSILON-BIOTECH?

What happened at EPSILON-BIOTECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 31, 2025 New annual accounts for financial year 2025: profit of € 17,279 (▼ 63% vs 2024). Source: NBB ↗
Dec 28, 1994 New establishment in Zonhoven. KBO
Dec 6, 1994 Start of the company according to the CBE. KBO

In short

From € 30,182 profit in 2022 to € 17,279 profit in 2025.

Paid € 24,091 in corporate taxes since 2022.

Best year ever: 2023, with € 51,910 profit.

Original PDFs at the National Bank ↗

Management

Eugenius Bosmans

EPSILON-BIOTECH

BEVER & MANNA

M LINK

Behind EPSILON-BIOTECH is Eugenius Bosmans. Eugenius Bosmans is also behind BEVER & MANNA and M LINK.

Directors

According to the 2025 annual accounts

Eugenius Bosmans

Director

Also active at: BEVER & MANNA, M LINK

Establishments

Establishment units

Physical locations of this company

Registered office

Beverzakbroekweg 91

3520 Zonhoven

2.069.534.689

Donderslagseweg 35

3520 Zonhoven

Active since 28 December 1994

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

BEVER & MANNA same network

€ 45,921 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP epsilon-biotech.be

Technologies

Nginx

Hosting & Email

Email provider

Self-hosted

Hosting

UNISERVER-AS, NL

Website info

HTTPS Nee

Features

Security

✗ HTTPS

✗ SPF

✗ DMARC

Details

Company number

0453.963.661

VAT number

BE 0453.963.661

Registered office

Beverzakbroekweg 91, 3520 Zonhoven

Names & denominations

EPSILON-BIOTECH

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 December 1994

Peppol

Active · Active since 15 Oct 2025

Contact

epsilon-biotech.be

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

Overige gespecialiseerde wetenschappelijke en technische activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

EPSILON-BIOTECH

Financials

What happened to EPSILON-BIOTECH?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions